2020
DOI: 10.3390/diagnostics10070483
|View full text |Cite
|
Sign up to set email alerts
|

Cardiovascular Risk and Statin Therapy Considerations in Women

Abstract: Despite major progress in the prevention and treatment of cardiovascular diseases, women remain an underdiagnosed and insufficiently treated group, with higher hospitalization and death rates compared to men. Obesity, more frequently encountered in women, raises the risk of metabolic syndrome and cardiovascular diseases as women age. There are some differences based on sex regarding the screening, diagnosis, and treatment of dyslipidemia, as it has been observed that women are less frequently prescribed statin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
48
0
4

Year Published

2020
2020
2023
2023

Publication Types

Select...
10

Relationship

3
7

Authors

Journals

citations
Cited by 65 publications
(53 citation statements)
references
References 121 publications
1
48
0
4
Order By: Relevance
“…We did not find correlation between MPV and mortality or adverse outcome on short term in the present study. MPV could be influenced by previous medication consisting of statin therapy as described in other studies [59][60][61] or EDTA can increase platelet size by causing platelet swelling.…”
Section: Discussionmentioning
confidence: 95%
“…We did not find correlation between MPV and mortality or adverse outcome on short term in the present study. MPV could be influenced by previous medication consisting of statin therapy as described in other studies [59][60][61] or EDTA can increase platelet size by causing platelet swelling.…”
Section: Discussionmentioning
confidence: 95%
“…In the general population, dyslipidemia and obesity have been identified to be predisposing factors for diabetes mellitus and increase CV risk in those patients [33]. Moreover, in women, the need for accurate diagnosis of obesity has been elucidated since it considerably increases the risk of CVD, and treatment of dyslipidemia may be challenging [34]. It is known that CVD pathogenesis differs concerning sex and that hypertrophic changes in the left ventricle in men are strongly associated with CV mortality [35].…”
Section: Discussionmentioning
confidence: 99%
“…The role of the increased content of intracellular calcium entering the cells under the action of prostaglandins and leading to cell destruction activated by neutral proteases is not excluded 17 . Various additional risk factors may contribute to the development of RM upon SS (statins, alcohol consumption, etc) 18 . In our patient, one additional factor may be considered the presence of diabetes mellitus.…”
Section: Discussionmentioning
confidence: 99%